• Jumo Health Broadening its Health Equity Approach

    Clinical Research News | Jumo Health launched a suite of services to drive health equity in clinical trials in 2023 via a collaboration with I Choose Life Foundation, a nonprofit dedicated to addressing health disparities in the African American community. It helped the company pilot its first community engagement event in the form of a workshop to train local business and faith leaders to serve as trusted messengers of information about clinical research and the point-of-care experience.

    Mar 12, 2025

  • Black Women with Breast Cancer Now Lead Champions of Clinical Trials

    Clinical Research News | For Black women diagnosed with breast cancer, the grim reality is that they are 41% more likely to die of the disease than white women. African American women are disproportionately affected by triple negative breast cancer (TNBC), the most aggressive form of the disease, but that only partially explains the discrepancy in the mortality rate.

    Mar 11, 2025

  • The Scope of Things: Sharing Patient Insights, Absence of Pregnant Women in Clinical Trials, Boosting Cancer Vaccine Work, More

    Clinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz delivers the news on how an AI-powered trial screening tool outperformed human research staff, a strategy report on boosting cancer vaccine work, the issue of continued absence of pregnant women in clinical trials, and more. Plus, Rare Patient Voice founder and president Wes Michael also joins in to talk about how his company is connecting people undertaking research studies with participants eager to share their insights.

    Mar 6, 2025

  • AstraZeneca Scaling Up Use of Generative AI to Help Reach 2030 Ambitions

    Clinical Research News | Generative artificial intelligence is being used by AstraZeneca to expedite its five-year ambitions to be an $80 billion company, deliver 20 new medicines, and be carbon negative. The initial value-driving activities include the creation of AI assistants to help with 3D location detection on CT scans and facilitate knowledge extraction for clinical documents as well as an intelligent protocol tool built in partnership with medical writers.

    Feb 4, 2025

  • Thermo Fisher Lupus Registry, Major Partnerships, Glaucoma Testing, More

    Clinical Research News | Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus (SLE) Registry; MedTech Innovator announced new industry partners; Seonix Bio announced the US launch of SightScore for primary open-angle glaucoma; and more.

    Feb 27, 2025

  • Follow the Money: Rare Muscle Disease Treatment, Huntington’s Disease Trial, More

    Clinical Research News | Abcuro is advancing to a Phase II/III trial to treat a rare, chronic inflammatory muscle disease called inclusion body myositis; Atalanta Therapeutics plans to start Phase I clinical trials of the company’s RNAi therapies for a genetic form of childhood epilepsy and for Huntington’s disease; and more.

    Feb 26, 2025

  • Regulators Support ‘Pragmatism’ in Clinical Trials

    Clinical Research News | A panel of experts from inside several major pharma companies discussed regulatory initiatives around pragmatic trials in depth at the recent Summit for Clinical Trial Ops Executives (SCOPE). Henry Wei, M.D., head of development innovation at Regeneron; Gracy Crane, international regulatory policy lead for real-world data at Roche Products Limited; Melodi J. McNeil, director of regulatory policy and intelligence at AbbVie; Stephanie Derbyshire, clinical operations portfolio leader at Roche; and Kevin Bugin, associate vice president of global regulatory policy and intelligence at Amgen were all part of the panel.

    Feb 25, 2025

  • Scope of Things: SCOPE 2025, Participant Engagement Award Winners, AI Helping With Clinical Trials, More

    Clinical Research News | In this month's episode of the Scope of Things, host Deborah Borfitz provides the latest on new criteria for defining and diagnosing obesity, the case for including pregnant women in vaccine trials, an inert gas being tested as an Alzheimer’s treatment, and more.

    Feb 21, 2025

  • USC to Use Generative AI to Make Cancer Clinical Trials More Efficient

    Clinical Research News | The Norris Comprehensive Cancer Center, owned and operated by the University of Southern California (USC) through its Keck School of Medicine, will serve as the initial testing ground for a platform powered by generative artificial intelligence (AI) that is designed to streamline clinical trial operations. This is the first U.S.-based academic site in the research network of California startup company Ryght.

    Feb 20, 2025

  • Fraud and Misconduct in Clinical Trials Not a Trivial Matter

    Clinical Research News | In a debate at the recent Summit for Clinical Ops Executives (SCOPE) over whether fraud and misconduct in clinical trials represent a marginal nuisance or a major problem, the argument for it being a serious situation easily won the day based on a show of hands in the room. Making the case for an embarrassment of breaches was Jonathan Rowe, head of R&D quality, operations and risk management at management consulting and technology firm ZS.

    Feb 18, 2025